Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: Optimization of the 4-substituted piperidine
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (19) , 5052-5056
- https://doi.org/10.1016/j.bmcl.2006.07.044
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone leadBioorganic & Medicinal Chemistry Letters, 2006
- Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[N2-[3,5-Dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: The First CGRP Antagonist for Clinical Trials in Acute MigraineJournal of Medicinal Chemistry, 2005
- Triptans Induce Vasoconstriction of Human Arteries and Veins from the Thoracic WallJournal of Cardiovascular Pharmacology, 2005
- The CGRP-Antagonist, BIBN4096BS Does not Affect Cerebral or Systemic Haemodynamics in Healthy VolunteersCephalalgia, 2005
- CGRP-Receptor Antagonists — A Fresh Approach to Migraine Therapy?New England Journal of Medicine, 2004
- Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of MigraineNew England Journal of Medicine, 2004
- Recognition of Privileged Structures by G-Protein Coupled ReceptorsJournal of Medicinal Chemistry, 2004
- New therapeutic target in primary headaches – blocking the CGRP receptorEmerging Therapeutic Targets, 2003
- New insights into the molecular actions of serotonergic antimigraine drugsPharmacology & Therapeutics, 2002
- Chapter 26. Privileged structures — An updatePublished by Elsevier ,2000